Neurocrine (NBIX): Qarzning balans kapitallashuviga nisbati
Dori vositalarini tashish paytida qat'iy harorat nazorati bilan bog'liq xarajatlar pul oqimiga ta'sir ko'rsatmoqda, bu esa joriy balans hisobotidagi leveraj koeffitsiyentida aks etgan. 0.12 qiymati ushbu baholash parametrini tavsiflaydi. Dori vositalariga bo'lgan yuqori talab tufayli biznes o'sishi bozor sikllaridan tezroq rivojlanmoqda, rahbariyatning R&D va patent himoyasi sohasidagi tajribasi esa Neurocrine Biosciences (NBIX) uchun keng ko'lamli kengayish imkoniyatlarini ochmoqda.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_NBIX_-_Neurocrine-Biosciences_-_Debt-to-Net-Assets-Ratio "NBIX: Neurocrine Biosciences, Inc. Qarzning balans kapitallashuviga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
NBIX (Neurocrine): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Neurocrine Biosciences|NBIX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Neurocrine Biosciences Inc|NBIX - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Neurocrine Corp|NBIX - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Neurocrine Biosciences|Tezkor likvidlik koeffitsiyenti neurocrine.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning fundamental tahlili:NBIX (Neurocrine Biosciences)
Neurocrine Biosciences (NBIX) ning nevrologiya sohasidagi ishlanmalarining yuqori daromadliligi kompaniyaga o'z kapital tuzilmasini samarali boshqarish va tashqi kreditlarga bog'liqlikni minimallashtirish imkonini beradi. Jami qarzdorlikning bozor kapitalizatsiyasiga nisbati 0.12 darajasida bo'lib, u qarz mablag'larining aktivlarning balans qiymatiga nisbatini aks ettiradi hamda patent portfelini rivojlantirish kontekstida moliyaviy richagning darajasi va biznes avtonomiyasini belgilaydi.
Muhim raqobatchilar
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar regencellbioscience.com RGC|AXSM - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ACAD (ACADIA Pharma)|Xenon Pharmaceuticals Inc (XENE) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Viking Therapeutics Corp (VKTX)|Qarzning balans kapitallashuviga nisbati Supernus Pharmaceuticals|Qarzning balans qiymatiga nisbati CPRX (catalystpharma.com)|Balans kapitallashuviga qarzlar DNLI|HRMY - Balans qiymatiga qarzlar|Biohaven Pharmaceutical - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Amylyx Corp AMLX|TRVI - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati PRAX (praxismedicines.com)|Anavex Life Sciences Corp. (AVXL) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar CeriBell Inc (CBLL)|PRTA (Prothena Corporation) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Alector Therapeutics (ALEC)|Qarzning balans kapitallashuviga nisbati Annexon, Inc. (ANNX)|OMER (omeros.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar NGNE (Neurogene)|Sof aktivlarga qarzlar AC Immune S.A. (ACIU)|VYGR - Qarzning balans kapitallashuviga nisbati|NMRA (Neumora Corp) - Qarzning balans qiymatiga nisbati|SCLX: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar tevogen.com (TVGN)|Qarzning balans qiymatiga nisbati ACOG|CGTX: Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar IKT|Qarzning balans kapitallashuviga nisbati SAVA (Cassava Pharma)|Balans kapitallashuviga qarzlar ASRT (Assertio)|Sof aktivlarga qarzlar Coya Therapeutics Inc (COYA)|VTGN - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Ovid Therapeutics Inc.|Acumen Pharma (ABOS) - Qarzning balans kapitallashuviga nisbati|CRVO - Sof aktivlarga qarzlar|ATHE (Alterity Therapeutics Ltd.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Clene Nanomedicine (CLNN)|Balans kapitallashuviga qarzlar PEPG|Sof aktivlarga qarzlar Jupiter Neurosciences, Inc.|Balans kapitallashuviga qarzlar RLMD (Relmada)|Annovis Bio Corporation (ANVS) - Balans qiymatiga qarzlar|GRCE - Qarzning balans kapitallashuviga nisbati|AIFF (fireflyneuro.com) - Qarzning balans qiymatiga nisbati|KLTO: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati NeuroSense Therapeutics Ltd.|RVPH (Reviva Pharmaceuticals Holdings) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar MetaVia, Inc. MTVA|Qarzning balans kapitallashuviga nisbati NeurAxis, Inc. (NRXS)|Sof aktivlarga qarzlar heliusmedical.com|Qarzning balans kapitallashuviga nisbati Passage Bio PASG|NEUP: Qarzning balans qiymatiga nisbati|Minerva Neurosciences Corp - Balans kapitallashuviga qarzlar|ATHA: Qarzning balans kapitallashuviga nisbati|ADXN: Balans kapitallashuviga qarzlar|ALZN - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati CYCN|Qarzning balans qiymatiga nisbati PTIX (Protagenic)|Qarzning balans kapitallashuviga nisbati Pasithea Therapeutics (KTTA)|cortigent.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ATXI (Avenue Therapeutics)|brainstorm-cell.com (BCLI) - Balans qiymatiga qarzlar|CARA: Qarzning balans qiymatiga nisbati|CHRO - Balans kapitallashuviga qarzlar|eliemtx.com (ELYM) - Qarzning balans kapitallashuviga nisbati|Intra-Cellular Therapies, Inc. - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|Balans qiymatiga qarzlar marinuspharma.com MRNS|Qarzning balans kapitallashuviga nisbati NKGen Biotech (NKGN)|NeuroBo Pharmaceuticals Inc - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar SAGE (Sage Therapeutics, Inc)|Synaptogenix, Inc (SNPX) - Balans qiymatiga qarzlar|TRVN: Qarzning balans qiymatiga nisbati|VIGL - Balans kapitallashuviga qarzlar|Anew Medical (WENA) - Qarzning balans kapitallashuviga nisbati|Cerevel Therapeutics Inc - Qarzning sof aktivlarga nisbati